Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 1, 1999, Pages 448-454

  Guo, Ailan ^a   Hu, Peidi ^a   Balimane, Praveen V ^a   Leibach, Frederick H ^a,b   Sinko, Patrick J ^a  

^a RUTGERS UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; VALACICLOVIR;

ANIMAL CELL; ARTICLE; CELL MEMBRANE TRANSPORT; CHO CELL; CONCENTRATION RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG STRUCTURE; FIRST PASS EFFECT; INTESTINE ABSORPTION; NONHUMAN; PH; PRIORITY JOURNAL;

ACYCLOVIR; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CARRIER PROTEINS; CHO CELLS; CRICETINAE; DIPEPTIDES; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; LACTAMS; RABBITS; RATS; SYMPORTERS; TRANSFECTION; VALINE;

EID: 0032916827     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. +/peptide symporter PepT1 expressed in Xenopus laevis oocytes. J Membr Biol 155:247-256.
2. Amidon GL and Lee HJ (1994) Absorption of peptide and peptidomimetic drugs. Annu Rev Pharmacol Toxicol 34:321-341.
3. Balimane PV, Tamai I, Guo A, Nakanishi T, Kitada H, Leibach FH, Tsuji A and Sinko PJ (1998) Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir. Biochem Biophys Res Commun 250:246-251.
4. Beauchamp LM, Orr GF, de Miranda P, Doucette M, Burnette T and Krenitsky (1992) Amino acid ester prodrugs of acyclovir. Antiviral Chem Chemother 3:157-164.
5. Boll M, Herget M, Wagener M, Weber WM, Markovich D, Biber J, Clauss W, Murer H and Daniel H (1996) Expression cloning and functional characterization of the kidney cortex high-affinity proton-coupled peptide transporter. Proc Natl Acad Sci USA 93:284-289.
6. Boll M, Markovich D, Weber WM, Korte H, Daniel H and Murer H (1994) Expression cloning of a cDNA from rabbit small intestine related to proton-coupled transport of peptides, beta-lactam antibiotics and ACE-inhibitors. Pfluegers Arch 429:146-149.
7. Bowers-Komro DM, Yamada Y and McCormick DB (1989) Substrate specificity and variables affecting efficiency of mammalian flavin adenine dinucleotide synthetase. Biochemistry 28:8439-8446.
8. Burnette T and de Miranda P (1994) Metabolic disposition of the acyclovir prodrug valacyclovir in the rat. Drug Metab Dispos 22:60-64.
9. Cook TJ, Jiansheng Y and Sinko PJ (1997) Involvement of the organic cation and oligopeptide carrier proteins in the apical transporter of vacyclovir across Caco-2 cell monolayers. Pharm Res 14 (Suppl):S-20.
10. Covitz K-MY, Amidon GL and Sadéem W (1996) Human dipeptide transporter, hPEPT1, stably transfected into Chinese hamster ovary cells. Pharm Res 13:1631-1634.
11. de Miranda P and Burnette TC (1994) Metabolic fate and pharmacokinetics of the acyclovir prodrug valacyclovir in cynomolgus monkeys. Drug Metab Dispos 22:55-59.
12. de Vrueh RLA, Smith PL and Lee C-P (1998) Transport of L-valine-acyclovir via the oligopeptide transporter in the human intestinal cell line, Caco-2. J Pharmacol Exp Ther 286:1166-1170.
13. Döring F, Dorn D, Bachfischer U, Amasheh S, Herget M and Danie H (1996) Functional analysis of a chimeric mammalian peptide transporter derived from the intestinal and renal isoforms. J Physiol 497:773-779.
14. Fei Y-J, Ganapathy V and Leibach FH (1998) Molecular and structural features of the proton-coupled oligopeptide transporter superfamily. Nucleic Acid Res Mol Biol Progress 58:239-261.
15. Fei Y-J, Kanai Y, Nussberger S, Ganapathy V, Leibach FH, Romero MF, Singh SK, Boron WF and Hediger MA (1994) Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature (London) 368:563-566.
16. Ganapathy ME, Brandsch M, Prasad PD, Ganapathy V and Leibach FH (1995) Differential recognition of β-lactam antibiotics by intestinal and renal peptide transporters, PEPT1 and PEPT2. J Biol Chem 270:25672-25677.
17. Ganapathy ME, Huang W, Wang H, Ganapathy V and Leibach FH (1998) Valacyclovir: A substrate for the intestinal and renal peptide transporters PEPT1l and PEPT2. Biochem Biophys Res Commun 246:470-475.
18. Ganapathy V and Leibach FH (1994) Expression and regulation of the taurine transporter in cultured cell lines of human origin. Adv Exp Med Biol 359:51-57.
19. Gray VA (1996) Change of pH requirements for simulated intestinal fluid TS. Pharmacopeial Forum 22:1943-1945.
20. Han H-k, Oh D-M and Amidon GL (1998) Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter. Pharm Res 15:1382-1386.
21. Hu P and Sinko PJ (1997) Carrier-mediated intestinal absorption of valacyclovir, the L-valyl ester prodrug of acyclovir. Involvement of multiple apical membrane transporters in rabbits. Pharm Res 14 (Suppl):S-29.
22. Jacobson MA (1993) Valacyclovir (BW256U87): The L-valyl ester of acyclovir. J Med Vir Suppl 1:150-153.
23. Lee CP, de Vrueh RLA and Smith PL (1996) Transport of a prodrug of acyclovir, L-val-acyclovir, via the oligopeptide transporter. Proc Inter Symp Control Rel Bioact Mater 23:47-48.
24. Liang R, Fei Y-J, Prasad PD, Ramamoorthy S, Han H, Yang-Feng TL, Hediger MA, Ganapathy V and Leibach FH (1995) Human intestinal H+/peptide cotransporter. J Biol Chem 270:6456-6463.
25. Lister N, Bailey PD, Collier ID, Boyd CAR and Bronk JR (1997) The influence of luminal pH on transport of neutral and charged dipeptides by rat small intestine, in vitro. Biochim Biophys Acta 1324:245-250.
26. Matthews DM (1991) Protein Absorption: Development and Present State of the Subject. Wiley-Liss, New York.
27. Miyamoto K, Shiraga T, Monta K, Yamamoto H, Haga H, Taketani Y, Tamai I, Sai Y, Tsuji A and Takeda E (1996) Sequence tissue distribution and developmental changes in rat intestinal oligopeptide transporter. Biochim Biophys Acta 1305:34-38.
28. Moseley RH, Jarose SM and Permoad P (1992) Organic cation transport by rat liver plasma membrane vesicles: Studies with tetraethylammonium. Am J Physiol 263:G775-G785.
29. Sinko PJ and Amidon GL (1989) Characterization of the oral absorption of betalactam antibiotics: II. Competitive absorption and peptide carrier specificity J Pharm Sci 78:723-727.
30. Sinko PJ and Balimane PV (1998) Carrier-mediated intestinal absorption of valacy-clovir, the L-valyl ester prodrug of acyclovir: 1. Interactions with peptides, organic anions, and organic cations in rats. Biopharm Drug Dispos 19:209-217.
31. Smith C, Klein A and Zimmerman T (1993) Influx of valacyclovir into cynomologous monkey intestinal brush border membranes is transporter mediated and enhanced over acyclovir. 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, abstract number 1750.
32. Soul-Lawton J, Seaber E, On N, Wootton R, Rolan P and Posner J (1995) Absolute bioavailability and metabolic disposition of valacyclovir, the L-valyl ester of acyclovir, following oral administration to humans. Antimicrob Agents Chemother 39:2759-2764.
33. Tamai I, Nakanishi T, Hayashi K, Terao T, Sai Y, Shiraga T, Miyamoto K, Takeda E, Higashida H and Tsuji A (1997) The predominant contribution of oligopeptide transporter PepT1 to intestinal absorption of beta-lactam antibiotics in the rat small intestine. J Pharm Pharmacol 49:796-801.
34. Temple CS, Bailey PD, Bronk JR and Boyd CAR (1996) A model for the kinetics of neutral and anionc dipeptide-proton cotransport by the apical membrane of rat kidney cortex. J Physiol 494:795-808
35. Temple CS, Bronk JR, Bailey PD and Boyd CAR (1995) Substrate-charge dependence of stoichiometry shows membrane potential is the driving force for proton-peptide cotransport in rat renal cortex. Pfluegers Arch 430:825-829.
36. Thwaites DT, Brown CD, Hirst BH and Simmons NL (1993a) Transepithelial glycylsarcosine transport in intestinal Caco-2 cells mediated by expression of H(+)-coupled carriers at both apical and basal membranes. J Biol Chem 268:7640-7642.
37. Thwaites DT, Brown CD, Hirst BH and Simmons NL (1993b) H(+)-coupled dipeptide (glycylsarcosine) transport across apical and basal borders of human intestinal Caco-2 cell monolayers display distinctive characteristics. Biochim Biophys Acta 1151:237-245.
38. Tsuji A and Tamai I (1996) Carrier-mediated intestinal transport of drugs. Pharm Res 13:963-977.
39. Wenzel U, Gebert I, Weintraut H, Weber W-M, Claub W and Daniel H (1996) Transport characteristics of differently charged cephalosporin antibiotics in ∞-cytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells. J Pharm Exp Ther 277:831-839.